Sales of New 'High-End' qPCR System Help Offset Flat Q3 Revenues for Life Tech's Molecular Bio Business

Life Tech executives said that the new qPCR instrument platform, called the ViiA 7, is just one of several innovations planned over the next several months to overhaul its qPCR business, and that its recent acquisitions in the digital and high-throughput PCR space would play a large part in that overhaul.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.